The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis

Published:2016-10 Issue:4 Volume:68 Page:554-563
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Badve Sunil V.,Palmer Suetonia C.,Strippoli Giovanni F.M.,Roberts Matthew A.,Teixeira-Pinto Armando,Boudville Neil,Cass Alan,Hawley Carmel M.,Hiremath Swapnil S.,Pascoe Elaine M.,Perkovic Vlado,Whalley Gillian A.,Craig Jonathan C.,Johnson David W.

Funder

Rutherford Discovery Fellowship

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Nephrology

Reference44 articles.

1. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events;Devereux;Circulation,1993

2. Surrogate markers for cardiovascular disease: structural markers;Mancini;Circulation,2004

3. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril;Mathew;Circulation,2001

4. Prognostic significance of left ventricular mass change during treatment of hypertension;Devereux;JAMA,2004

5. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events;Okin;JAMA,2004

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of left ventricular structure and strain in chronic kidney disease patients by cardiovascular magnetic resonance imaging: a retrospective study;PeerJ;2024-08-02

2. Aortic arch calcification increases major adverse cardiac event risk, modifiable by echocardiographic left ventricular hypertrophy, in end-stage kidney disease patients;Therapeutic Advances in Chronic Disease;2024-01

3. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association;Cardiovascular Research;2023-05-30

4. Implications of uremic cardiomyopathy for the practicing clinician: an educational review;Heart Failure Reviews;2023-05-12

5. Cardiac Imaging Biomarkers in Chronic Kidney Disease;Biomolecules;2023-04-29